Database : HANSEN
Search on : TESTE TUBERCULINICO [Subject descriptor]
References found : 14 [refine]
Displaying: 1 .. 14   in format [Detailed]

page 1 de 1

  1 / 14 HANSEN  
              next record last record
select
to print
Id:17318
Author:Black, Gillian F; Weir, Rosemari E; Chaguluka, Steven D; Warndorff, David; Crampin, Amelia C; Mwaungulu, Lorren; Sichali, Lifted; Floyd, Sian; Bliss, Lyn; Jarman, Elizabeth; Docovan, Linda; Andersen, Peter; Britton, Warwick; Hewinson, Glyn; Huygen, Kris; Paulsen, Jean; Sing, Mahavir; Prestidge, Ross; Fine, Paul E. M; Dockrell, Hazel M
Title:Gama interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-Mycobacterium bovis BCG-vaccinated Malawian young adults ..-
Source:s.l; s.n; 2003. 10 p. graf.
Abstract:We have previously shown that young adults living in a rural area of northern Malawi showed greater gamma interferon (IFN-gamma) responses to purified protein derivatives (PPD) prepared from environmental mycobacteria than to PPD from Mycobacterium tuberculosis. In order to define the mycobacterial species to which individuals living in a rural African population have been exposed and sensitized, we tested T-cell recognition of recombinant and purified antigens from M. tuberculosis (38 kDa, MPT64, and ESAT-6), M. bovis (MPB70), M. bovis BCG (Ag85), and M. leprae (65 kDa, 35 kDa, and 18 kDa) in >600 non-M. bovis BCG-vaccinated young adults in the Karonga District of northern Malawi. IFN-gamma was measured by enzyme-linked immunosorbent assay (ELISA) in day 6 supernatants of diluted whole-blood cultures. The recombinant M. leprae 35-kDa and 18-kDa and purified native M. bovis BCG Ag85 antigens induced the highest percentages of responders, though both leprosy and bovine tuberculosis are now rare in this population. The M. tuberculosis antigens ESAT-6 and MPT64 and the M. bovis antigen MPB70 induced the lowest percentages of responders. One of the subjects subsequently developed extrapulmonary tuberculosis; this individual had a 15-mm-diameter reaction to the Mantoux test and responded to M. tuberculosis PPD, Ag85, MPT64, and ESAT-6 but not to any of the leprosy antigens. We conclude that in this rural African population, exposure to M. tuberculosis or M. bovis is much less frequent than exposure to environmental mycobacteria such as M. avium, which have antigens homologous to the M. leprae 35-kDa and 18-kDa antigens. M. tuberculosis ESAT-6 showed the strongest association with the size of the Mantoux skin test induration, suggesting that among the three M. tuberculosis antigens tested it provided the best indication of exposure to, or infection with, M. tuberculosis. (AU).
Descriptors:Antígenos de Bactérias/*IM
Vacina BCG/*IM
Interferon Tipo II/*BI
Hanseníase/EP
Malauí/EP
Mycobacterium/GE/*IM
Mycobacterium bovis/IM
Mycobacterium leprae/IM
Mycobacterium tuberculosis/IM
Proteínas Recombinantes de Fusão/IM
Especificidade de Espécies
Linfócitos T/IM
Teste Tuberculínico
Tuberculose/IM
Vacinação
Limits:Adolescente
Adulto
Criança
Estudo Comparativo
Feminino
Humano
Masculino
População Rural
Location:BR191.1; 00224/s


  2 / 14 HANSEN  
              first record previous record next record last record
select
to print
Id:15815
Author:Convit, Jacinto.
Title:Lepromin and tuberculin tests in Venezuelan leprosy foci, induction of lepromin reactivity by BCG vaccination.
Source:Int. J. Lepr;22(3):303-310, July-Sept. 1954. tab, graf.
Abstract:The reactions to tuberculin and lepromin were studied in 8,353 inhabitants of leprosy foci in rural areas in Venezuela. Of this general group, a total of 1,356 (16.2 per cent) proved to be negative to the Mitsuda, test, while 5,205 (62.5 per cent) were Mantoux negative, In the group of Mitsuda-positive persons 44.8 per cent were also Mantoux positive, while in the Mitsuda-negative group only 3 per cent were Mantoux positive. In the Mantoux-positive group 99.5 per cent were Mitsuda-positive, while in the Mantoux-negative group 74.4 per cent were Mitsuda-positive. Considering that 16.2 per cent of the persons examined were found to be without protection against leprosy in the first tests, and taking into account that almost all lepromatous and indeterminate cases come from the lepromin negatives, which form the endemic matrix of the disease, there can be no doubt but that BCG vaccination will be an effective prophylaxis, at least in rural areas, when it can reduce the percentage of Mitsuda negative from 16.2 to 1.3 per cent. (AU).
Descriptors:HANSENIASE
HANSENIASE/diag
HANSENIASE/terap
TESTE TUBERCULINICO/clas
HANSENIASE/prev
Electronic Medium:http://www.ilsl.br
Location:BR191.1


  3 / 14 HANSEN  
              first record previous record next record last record
select
to print
Id:13666
Author:Bala, Lakshmi; Anand, Sukumar; Sinha, Sudhir
Title:Enhancement of human T cell response to a peptide epitope of 38kDa antigen of Mycobacterium tuberculosis by liposomes ..-
Source:s.l; s.n; 2002. 9 p. graf.
Abstract:Diagnosis of tuberculosis a problem, specially in the regions harboring an abundance of both pathogenic and non-pathogenic mycobacteria. This study was undertaken to assess in such a situation the predictive value of proliferative T cell response to a peptide epitope ('38G') of the 38 kDa membrane protein of Mycobacterium tuberculosis. 3[H]-thymidine incorporation assays were done with peripheral blood mononuclear cells of tuberculoid leprosy and pulmonary tuberculosis patients. The donors were also classified as PPD responders (Stimulation Index, SI> 3) or non-responders (SI < or = 3) on the basis of their T cell response to the 'Purified Protein Derivative (PPD)' of M. tuberculosis. 38G peptide was used in either free or liposome-associated form prepared by the technique of 'Dehydration-rehydration Vesicles' (Kirby and Gregoriadis, 1984). While free peptide failed to induce a positive response in study subjects, its liposomal form was T cell stimulatory and distinguished, to certain extent, between PPD responders (corresponding SI > 3 in 54 per cent subjects) and non-responders (SI > 3 in 29 per cent subjects). However, it did not differentiate between leprosy and tuberculosis. The study supports use of liposomes as adjuvant vehicles for antigenic peptides designed to activate human T cells. (AU).
Descriptors:ANTIGENOS DE BACTERIAS/admin
ANTIGENOS DE BACTERIAS/quim
ANTIGENOS DE BACTERIAS/genet
HANSENIASE TUBERCULOIDE/diag
HANSENIASE TUBERCULOIDE/imunol
EPITOPOS/admin
EPITOPOS/quim
EPITOPOS/genet
DIAGNOSTICO DIFERENCIAL
MYCOBACTERIUM TUBERCULOSIS/quim
MYCOBACTERIUM TUBERCULOSIS/genet
MYCOBACTERIUM TUBERCULOSIS/imunol
DADOS DE SEQUÊNCIA MOLECULAR
SEQUÊNCIA DE AMINOACIDOS
LINFOCITOS T/imunol
TESTE TUBERCULINICO
TUBERCULOSE PULMONAR/diag
TUBERCULOSE PULMONAR/imunol
TRANSFORMACAO LINFOCITICA
LIPOSSOMOS
 PESO MOLECULAR
Limits:ESTUDO COMPARATIVO
HUMANO
IN VITRO
SUPPORT, NON-U.S. GOV'T
Electronic Medium:http://www.ilsl.br
Location:BR191.1; 09061/s


  4 / 14 HANSEN  
              first record previous record next record last record
select
to print
Id:13317
Author:Stanley, Susan J; Howland, C; Stone, Mary M; Sutherland, I
Title:BCG vaccination of children against leprosy in Uganda: final results ..-
Source:s.l; s.n; oct. 1981. 16 p. tab.
Abstract:A total of 19200 children, all contacts or realtives of known leprosy patients, anda all free of visible leprosy lesions, were included in a controlled trial of BCG vaccination against leprosy in Uganda between 1960 and 1964.(AU).
Descriptors:VACINA BCG
SEGUIMENTOS
HANSENIASE/epidemiol
HANSENIASE/prev
TESTE TUBERCULINICO
UGANDA
VACINACAO
FATORES DE TEMPO
Limits:HUMANO
PRÉ-ESCOLAR
CRIANÇA
ADOLESCENTE
Electronic Medium:http://www.ilsl.br
Location:BR191.1; 01183/s


  5 / 14 HANSEN  
              first record previous record next record last record
select
to print
Id:12277
Author:Fine, P. E. M; Floyd, S; Stanford, J. L; Nkhosa, P; Kasunga, A; Chaguluka, S; Warndorff, D. K; Jenkins, P. A; Yates, M; Ponnighaus, J. M
Title:Environmental mycobacteria in northern Malawi: implications for the epidemiology of tuberculosis and leprosy ..-
Source:s.l; s.n; 2001. 9 p. tab, graf.
Descriptors:ADOLESCENCIA
DISTRIBUIÇAO POR IDADE
ANTIGENOS DE BACTÉRIAS
CRIANÇA
EXPOSIÇAO AMBIENTAL
SEGUIMENTOS
INCIDENCIA
HANSENIASE
HANSENIASE
HANSENIASE
MALAUI
MYCOBACTERIUM
MYCOBACTERIUM
MYCOBACTERIUM
MYCOBACTERIUM
VIGILANCIA DA POPULAÇAO
QUESTIONARIOS
FATORES DE RISCO
SAUDE RURAL
DISTRIBUIÇAO POR SEXO
PELE
MICROBIOLOGIA DO SOLO
TESTE TUBERCULINICO
TUBERCULOSE
TUBERCULOSE
TUBERCULOSE
MICROBIOLOGIA DA AGUA
Location:BR191.1; 08629/s


  6 / 14 HANSEN  
              first record previous record next record last record
select
to print
Id:11888
Author:Siddiqui, M. Ruby; Moreira, Andre L; Negesse, Yohannes; Taye, Genet A; Hanekom, Willem A; Haslett, Patrick A; Britton, Swen; Kaplan, Gilla
Title:Local nerve damage in leprosy does not lead to an impaired cellular immune response or decreased wound healing in the skin ..-
Source:s.l; s.n; 2002. 6 p. ilus, tab.
Descriptors:HANSENIASE
HANSENIASE
HANSENIASE
ANTIGENOS CD1
ANTIGENOS CD13
ANTIGENOS CD18
BIOPSIA
HIPERSENSIBILIDADE TARDIA
IMUNOHISTOQUIMICA
MYCOBACTERIUM LEPRAE
NEURITE
NEURITE
NEURITE
TESTE TUBERCULINICO
CICATRIZAÇAO DE FERIDAS
Location:BR191.1; 08577/s


  7 / 14 HANSEN  
              first record previous record next record last record
select
to print
Id:11489
Author:Fine, P. E. M; Floyd, S; Stanford, J. L; Nkhosa, P; Kasunga, A; Chaguluka, S; Warndorff, D. K; Jenkins, P. A; Yates, M; Ponnighaus, J. M
Title:Environmental mycobacteria in northern Malawi: implications for the epidemiology of tuberculosis and leprosy ..-
Source:s.l; s.n; 2001. 9 p. tab, graf.
Descriptors:HANSENIASE
HANSENIASE
HANSENIASE
MYCOBACTERIUM
MYCOBACTERIUM
MYCOBACTERIUM
MYCOBACTERIUM
INCIDENCIA
MALAUI
VIGILANCIA DA POPULAÇAO
FATORES DE RISCO
SAUDE RURAL
DISTRIBUIÇAO POR SEXO
PELE
MICROBIOLOGIA DO SOLO
TESTE TUBERCULINICO
TUBERCULOSE
TUBERCULOSE
TUBERCULOSE
MICROBIOLOGIA DA AGUA
ANTIGENOS DE BACTÉRIAS
Location:BR191.1; 08359/s


  8 / 14 HANSEN  
              first record previous record next record last record
select
to print
Id:11013
Author:Bottasso, Oscar; Merlin, Victor; Cannon, Leslie; Cannon, Helen; Ingledew, Nicholas; Keni, Manjusha; Hartopp, Richard; Stanford, Cynthia; Stanford, John
Title:Studies of vaccination of persons in close contact with leprosy patients in Argentina ..-
Source:s.l; s.n; 1998. 6 p. tab.
Descriptors:HANSENIASE
HANSENIASE
MYCOBACTERIUM
MYCOBACTERIUM BOVIS
PREVALENCIA
TESTE TUBERCULINICO
VACINAÇAO
Limits:ADULTO
CRIANCA
HUMANO
Location:BR191.1; 07289/s


  9 / 14 HANSEN  
              first record previous record next record last record
select
to print
Id:10325
Author:Rafi, Abdolnasser; Feval, Francois
Title:PCR to detect mycobacterium tuberculosis DNA in sputum samples from treated leprosy patients with putative tuberculosis ..-
Source:s.l; s.n; 1995. 5 p. tab.
Descriptors:FATORES ETARIOS
SEQUENCIA DE BASES
ESTUDOS DE CASOS E CONTROLES
DNA BACTERIANO
INCIDENCIA
IRA (GEOGRAFICO)
HANSENIASE
DADOS DE SEQUENCIA MOLECULAR
MYCOBACTERIUM TUBERCULOSIS
MYCOBACTERIUM TUBERCULOSIS
REAÇAO EM CADEIA POR POLIMERASE
SENSIBILIDADE E ESPECIFICIDADE
ESCARRO
TESTE TUBERCULINICO
TUBERCULOSE
TUBERCULOSE
TUBERCULOSE
Location:BR191.1; 07175/s


  10 / 14 HANSEN  
              first record previous record next record last record
select
to print
Id:9331
Author:Barnes, Peter F; Grisso, Cara L; Abrams, John S; Brand, Hamid; Rea, Thomas H; Modlin, Robert L
Title:yS T lymphocytes in human tuberculosis ..-
Source:Chicago; s.n; 1992. 7 p. tab, graf.
Descriptors:LINHAGEM CELULAR
CITOCINAS
HANSENIASE
CONTAGEM DE LEUCOCITOS
TRANSFORMAÇAO LINFOCITICA
MYCOBACTERIUM TUBERCULOSIS
LINFOCITOS T
TESTE TUBERCULINICO
TUBERCULOSE MILIAR
TUBERCULOSE PLEURAL
TUBERCULOSE PULMONAR
Location:BR191.1; 06471/s


  11 / 14 HANSEN  
              first record previous record next record last record
select
to print
Id:9305
Author:Pazin Filho, Antonio; Bueno, Claudia Dizioli Franco; Pinheiro, Sandra de Azevedo; Ruffino Netto, Antonio
Title:Estudos de intervencao sobre vacinacao BCG em hanseniase: uma analise comparativa Trial studies about BCG vaccination against leprosy: a comparative analysis-
Source:Ribeirao Preto; s.n; 1993. 6 p. tab.
Descriptors:VACINA BCG
ESTUDOS DE INTERVENÇAO
UGANDA
NOVA GUINÉ
SEGUIMENTOS
MÉTODO DUPLO-CEGO
MÉTODO SIMPLES-CEGO
AMOSTRAGEM ESTRATIFICADA
TESTE TUBERCULINICO
HANSENIASE
HANSENIASE
HANSENIASE
MIANMA
LACTENTE
PRÉ-ESCOLAR
ADOLESCENCIA
RECÉM-NASCIDO
Location:BR191.1; 06214/s


  12 / 14 HANSEN  
              first record previous record next record last record
select
to print
Id:7209
Author:Fine, P. E. M; Gruer, P. J. K; Maine, N; Ponnighaus, J. M; Rees, R. J. W; Stanford, J. L
Title:Failure of Mycobacterium leprae soluble antigens to suppress delayed-type hypersensivity reaction to tuberculin ..-
Source:s.l; s.n; 1989. 4 p. graf.
Descriptors:HANSENIASE
HANSENIASE
TESTE TUBERCULINICO
Location:BR191.1; 05535/s


  13 / 14 HANSEN  
              first record previous record next record last record
select
to print
Id:3841
Author:Mendes, Ernesto; Raphael, Açucena; Mota, Norma G. S; Mendes, Nelson F
Title:Cell-mediated immunity in leprosy and transfer of delayed hypersensivity reactions ..-
Source:s.l; s.n; 1974. 7 p. tab.
Descriptors:HANSENIASE
ANTIBIOTICOS ANTIMICOTICOS
ANTIGENOS
HIPERSENSIBILIDADE TARDIA
IMUNIDADE CELULAR
IMUNIZAÇAO
IMUNIZAÇAO PASSIVA
ANTIGENO DE MITSUDA
LINFOCITOS
NITROBENZENOS
TESTES CUTANEOS
TRICOFITINA
TESTE TUBERCULINICO
Location:BR191.1; 02681/s


  14 / 14 HANSEN  
              first record previous record
select
to print
Id:3800
Author:Myrvang, B; Godal, T; Ridley, D. S; Fröland, S. S; Song, Y. K
Title:Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy ..-
Source:s.l; s.n; 1973. 13 p. graf.
Descriptors:MYCOBACTERIUM LEPRAE
INIBIÇAO DE MIGRAÇAO CELULAR
HANSENIASE
HANSENIASE
HANSENIASE
LEUCOCITOS
LEUCOCITOS
TRANSFORMAÇAO LINFOCITICA
MYCOBACTERIUM BOVIS
PELE
TESTES CUTANEOS
TIMIDINA
TRITIO
TESTE TUBERCULINICO
Location:BR191.1; 02640/s



page 1 de 1
   


Refine the search
  Database : HANSEN Advanced form   
Search for : Free form   

    Search in field  
1  
2
3
 
           



Search engine: iAH powered by WWWISIS

IAH - © BIREME/PAHO/WHO
Latin American and Caribbean Center on Health Sciences Information